Figure 6 | Cell Death & Disease

Figure 6

From: Nanoencapsulation of ABT-737 and camptothecin enhances their clinical potential through synergistic antitumor effects and reduction of systemic toxicity

Figure 6

Molecular insights into the synergistic action of ABT-737 and CPT. (a) Caspase 9 and caspase 8 activity, mean±S.D., n=3, and (b) western blot analysis of key pro- and antiapoptotic proteins after treatment with the indicated doses of ABT-737 and CPT in single- or dual-loaded NPs for 24 h (HCT116, RKO) or 48 h (HT29)

Back to article page